US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 2.730
  • 0.0000.00%
Close Nov 1 16:00 ET
  • 2.800
  • +0.070+2.56%
Post 20:01 ET
804.44MMarket Cap-5150P/E (TTM)

AbCellera Biologics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-250.56%-29.97M
5.34%-41.71M
-115.82%-43.88M
-163.44%-19.61M
99.92%-106K
-92.71%19.9M
-143.97%-44.06M
13.40%277.36M
284.97%30.91M
-2,037.32%-126.79M
Net income from continuing operations
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
3.29%158.52M
-149.86%-29.89M
224.52%26.62M
Depreciation and amortization
424.21%38.04M
-4.97%6.77M
-6.67%30.89M
-40.70%9.11M
10.12%7.41M
20.11%7.26M
43.17%7.12M
91.90%33.1M
215.85%15.36M
59.96%6.73M
Deferred tax
----
----
192.72%1.96M
----
----
----
----
-4.76%-2.11M
----
----
Other non cash items
-5,034.59%-40.82M
146.97%1.71M
-190.57%-7.74M
-126.45%-1.39M
-153.44%-1.93M
-370.41%-795K
-513.85%-3.63M
139.41%8.55M
-11.87%5.24M
232.62%3.6M
Change In working capital
-129.14%-8.04M
-17.75%-26.98M
-55.66%13.23M
-95.14%1.41M
104.08%7.16M
-89.45%27.57M
73.05%-22.91M
-28.43%29.83M
130.68%28.99M
-2,907.01%-175.49M
-Change in receivables
50.73%-15.86M
-208.16%-18.58M
-134.44%-36.66M
-115.78%-10.44M
81.10%-11.21M
-111.65%-32.18M
109.72%17.18M
373.60%106.46M
148.11%66.17M
-481.07%-59.33M
-Change in payables and accrued expense
-94.86%1.98M
76.74%-8.06M
-621.30%-15.1M
-166.41%-25.68M
105.69%6.78M
353.71%38.45M
-137.02%-34.65M
35.31%-2.09M
-27.28%38.68M
-532.93%-119.19M
-Change in other current assets
73.33%2.13M
40.54%-3.61M
753.09%8.98M
3,228.19%4.66M
214.18%9.15M
-64.01%1.23M
19.77%-6.06M
59.33%-1.38M
-136.88%-149K
766.96%2.91M
-Change in other working capital
-81.50%3.71M
425.97%3.26M
176.55%56.01M
143.42%32.87M
2,141.28%2.44M
728.16%20.08M
-88.97%620K
-383.44%-73.16M
-616.63%-75.7M
-98.81%109K
Cash from discontinued investing activities
Operating cash flow
-250.56%-29.97M
5.34%-41.71M
-115.82%-43.88M
-163.44%-19.61M
99.92%-106K
-92.71%19.9M
-143.97%-44.06M
13.40%277.36M
284.97%30.91M
-2,037.32%-126.79M
Investing cash flow
Cash flow from continuing investing activities
251.49%52.1M
119.99%29.91M
37.30%-221.11M
-42.55%-24.32M
95.47%-12.79M
-26.45%-34.39M
-467.32%-149.61M
-6.13%-352.63M
-1,385.03%-17.06M
-4.59%-281.99M
Net PPE purchase and sale
26.07%-20.11M
-61.11%-24.14M
-8.90%-76.95M
-17.04%-14.43M
-62.48%-20.33M
13.16%-27.2M
-3.37%-14.98M
-20.89%-70.66M
-30.75%-12.33M
-45.94%-12.51M
Net intangibles purchase and sale
----
----
72.00%-560K
--0
----
----
----
---2M
--0
----
Net business purchase and sale
-122.91%-4.91M
-32.18%-5.91M
46.69%-13.69M
41.17%-3.48M
13.13%-3.54M
70.05%-2.2M
46.38%-4.47M
38.54%-25.68M
-83.62%-5.91M
77.42%-4.08M
Net investment purchase and sale
746.36%64.54M
139.74%52.79M
42.66%-155.22M
-1,342.49%-16.7M
101.60%4.32M
-266.92%-9.99M
-2,064.72%-132.85M
-2.30%-270.72M
89.77%-1.16M
-8.51%-269.41M
Net other investing changes
151.64%12.58M
166.17%7.17M
54.02%25.31M
340.79%10.29M
22.13%7.33M
-9.12%5M
3.74%2.69M
-49.62%16.43M
-89.77%2.33M
13.52%6M
Cash from discontinued investing activities
Investing cash flow
251.49%52.1M
119.99%29.91M
37.30%-221.11M
-42.55%-24.32M
95.47%-12.79M
-26.45%-34.39M
-467.32%-149.61M
-6.13%-352.63M
-1,385.03%-17.06M
-4.59%-281.99M
Financing cash flow
Cash flow from continuing financing activities
532.70%2.65M
718.12%2.83M
736.12%10.36M
978.80%3.77M
34,994.74%6.63M
-64.28%419K
85.37%-458K
58.11%-1.63M
-80.97%349K
-102.12%-19K
Net issuance payments of debt
----
----
320.69%11.59M
1,031.81%3.95M
----
----
----
-49.79%2.76M
-96.46%349K
--231K
Proceeds from stock option exercised by employees
38.02%461K
82.04%892K
----
----
----
--334K
--490K
----
----
----
Net other financing activities
2,476.47%2.19M
304.54%1.94M
71.85%-1.23M
---185K
25.60%-186K
-90.95%85K
81.31%-948K
53.24%-4.38M
--0
---250K
Cash from discontinued financing activities
Financing cash flow
532.70%2.65M
718.12%2.83M
736.12%10.36M
978.80%3.77M
34,994.74%6.63M
-64.28%419K
85.37%-458K
58.11%-1.63M
-80.97%349K
-102.12%-19K
Net cash flow
Beginning cash position
-31.52%150.86M
-61.27%160.61M
-17.26%414.65M
-50.08%199.71M
-74.67%207.04M
-61.46%220.31M
-17.26%414.65M
-15.65%501.14M
-22.72%400.09M
3.14%817.44M
Current changes in cash
276.17%24.78M
95.38%-8.97M
-231.15%-254.63M
-382.92%-40.17M
98.47%-6.26M
-105.70%-14.07M
-374.52%-194.13M
16.01%-76.89M
188.59%14.2M
-48.84%-408.8M
Effect of exchange rate changes
-105.40%-43K
-266.67%-781K
106.14%589K
193.41%1.07M
87.57%-1.06M
166.03%797K
-4.41%-213K
-573.61%-9.6M
169.33%364K
-3,841.01%-8.55M
End cash Position
-15.18%175.6M
-31.52%150.86M
-61.27%160.61M
-61.27%160.61M
-50.08%199.71M
-74.67%207.04M
-61.46%220.31M
-17.26%414.65M
-17.26%414.65M
-22.72%400.09M
Free cash flow
-586.16%-50.08M
-11.52%-65.85M
-159.30%-121.38M
-283.20%-34.04M
85.14%-21M
-103.02%-7.3M
-168.88%-59.05M
9.98%204.7M
171.08%18.58M
-874.07%-141.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -250.56%-29.97M5.34%-41.71M-115.82%-43.88M-163.44%-19.61M99.92%-106K-92.71%19.9M-143.97%-44.06M13.40%277.36M284.97%30.91M-2,037.32%-126.79M
Net income from continuing operations -20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M3.29%158.52M-149.86%-29.89M224.52%26.62M
Depreciation and amortization 424.21%38.04M-4.97%6.77M-6.67%30.89M-40.70%9.11M10.12%7.41M20.11%7.26M43.17%7.12M91.90%33.1M215.85%15.36M59.96%6.73M
Deferred tax --------192.72%1.96M-----------------4.76%-2.11M--------
Other non cash items -5,034.59%-40.82M146.97%1.71M-190.57%-7.74M-126.45%-1.39M-153.44%-1.93M-370.41%-795K-513.85%-3.63M139.41%8.55M-11.87%5.24M232.62%3.6M
Change In working capital -129.14%-8.04M-17.75%-26.98M-55.66%13.23M-95.14%1.41M104.08%7.16M-89.45%27.57M73.05%-22.91M-28.43%29.83M130.68%28.99M-2,907.01%-175.49M
-Change in receivables 50.73%-15.86M-208.16%-18.58M-134.44%-36.66M-115.78%-10.44M81.10%-11.21M-111.65%-32.18M109.72%17.18M373.60%106.46M148.11%66.17M-481.07%-59.33M
-Change in payables and accrued expense -94.86%1.98M76.74%-8.06M-621.30%-15.1M-166.41%-25.68M105.69%6.78M353.71%38.45M-137.02%-34.65M35.31%-2.09M-27.28%38.68M-532.93%-119.19M
-Change in other current assets 73.33%2.13M40.54%-3.61M753.09%8.98M3,228.19%4.66M214.18%9.15M-64.01%1.23M19.77%-6.06M59.33%-1.38M-136.88%-149K766.96%2.91M
-Change in other working capital -81.50%3.71M425.97%3.26M176.55%56.01M143.42%32.87M2,141.28%2.44M728.16%20.08M-88.97%620K-383.44%-73.16M-616.63%-75.7M-98.81%109K
Cash from discontinued investing activities
Operating cash flow -250.56%-29.97M5.34%-41.71M-115.82%-43.88M-163.44%-19.61M99.92%-106K-92.71%19.9M-143.97%-44.06M13.40%277.36M284.97%30.91M-2,037.32%-126.79M
Investing cash flow
Cash flow from continuing investing activities 251.49%52.1M119.99%29.91M37.30%-221.11M-42.55%-24.32M95.47%-12.79M-26.45%-34.39M-467.32%-149.61M-6.13%-352.63M-1,385.03%-17.06M-4.59%-281.99M
Net PPE purchase and sale 26.07%-20.11M-61.11%-24.14M-8.90%-76.95M-17.04%-14.43M-62.48%-20.33M13.16%-27.2M-3.37%-14.98M-20.89%-70.66M-30.75%-12.33M-45.94%-12.51M
Net intangibles purchase and sale --------72.00%-560K--0---------------2M--0----
Net business purchase and sale -122.91%-4.91M-32.18%-5.91M46.69%-13.69M41.17%-3.48M13.13%-3.54M70.05%-2.2M46.38%-4.47M38.54%-25.68M-83.62%-5.91M77.42%-4.08M
Net investment purchase and sale 746.36%64.54M139.74%52.79M42.66%-155.22M-1,342.49%-16.7M101.60%4.32M-266.92%-9.99M-2,064.72%-132.85M-2.30%-270.72M89.77%-1.16M-8.51%-269.41M
Net other investing changes 151.64%12.58M166.17%7.17M54.02%25.31M340.79%10.29M22.13%7.33M-9.12%5M3.74%2.69M-49.62%16.43M-89.77%2.33M13.52%6M
Cash from discontinued investing activities
Investing cash flow 251.49%52.1M119.99%29.91M37.30%-221.11M-42.55%-24.32M95.47%-12.79M-26.45%-34.39M-467.32%-149.61M-6.13%-352.63M-1,385.03%-17.06M-4.59%-281.99M
Financing cash flow
Cash flow from continuing financing activities 532.70%2.65M718.12%2.83M736.12%10.36M978.80%3.77M34,994.74%6.63M-64.28%419K85.37%-458K58.11%-1.63M-80.97%349K-102.12%-19K
Net issuance payments of debt --------320.69%11.59M1,031.81%3.95M-------------49.79%2.76M-96.46%349K--231K
Proceeds from stock option exercised by employees 38.02%461K82.04%892K--------------334K--490K------------
Net other financing activities 2,476.47%2.19M304.54%1.94M71.85%-1.23M---185K25.60%-186K-90.95%85K81.31%-948K53.24%-4.38M--0---250K
Cash from discontinued financing activities
Financing cash flow 532.70%2.65M718.12%2.83M736.12%10.36M978.80%3.77M34,994.74%6.63M-64.28%419K85.37%-458K58.11%-1.63M-80.97%349K-102.12%-19K
Net cash flow
Beginning cash position -31.52%150.86M-61.27%160.61M-17.26%414.65M-50.08%199.71M-74.67%207.04M-61.46%220.31M-17.26%414.65M-15.65%501.14M-22.72%400.09M3.14%817.44M
Current changes in cash 276.17%24.78M95.38%-8.97M-231.15%-254.63M-382.92%-40.17M98.47%-6.26M-105.70%-14.07M-374.52%-194.13M16.01%-76.89M188.59%14.2M-48.84%-408.8M
Effect of exchange rate changes -105.40%-43K-266.67%-781K106.14%589K193.41%1.07M87.57%-1.06M166.03%797K-4.41%-213K-573.61%-9.6M169.33%364K-3,841.01%-8.55M
End cash Position -15.18%175.6M-31.52%150.86M-61.27%160.61M-61.27%160.61M-50.08%199.71M-74.67%207.04M-61.46%220.31M-17.26%414.65M-17.26%414.65M-22.72%400.09M
Free cash flow -586.16%-50.08M-11.52%-65.85M-159.30%-121.38M-283.20%-34.04M85.14%-21M-103.02%-7.3M-168.88%-59.05M9.98%204.7M171.08%18.58M-874.07%-141.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data